Principal Investigators

    KODADEK, THOMAS J.

    Institution

    SCRIPPS FLORIDA

    Contact information of lead PI

    Country

    USA

    Title of project or programme

    Discovery of antibody biomarkers for Alzheimer’s Disease

    Source of funding information

    NIH (NIA)

    Total sum awarded (Euro)

    484403.6697

    Start date of award

    01/05/2016

    Total duration of award in years

    1

    Keywords

    Acquired Cognitive Impairment... Aging... Alzheimer's Disease... Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)... Brain Disorders... Dementia... Immune System... Neurodegenerative... Neurosciences... Prevention... Translational Research

    Research Abstract

    ? DESCRIPTION (provided by applicant): The discovery of serum biomarkers for Alzheimer’s disease (AD) represents an enormous unmet medical need. This project will further explore the hypothesis that the adaptive immune system might react to unusual antigens produced as a result of AD pathology and as a result produce high levels of antibodies that would not be found in a normal individual. There is some evidence that this is the case. To discover these antibodies we plan to screen large libraries of bead-displayed synthetic oligomers and find compounds that retain far more antibodies from AD serum samples than from controls. These molecules would be employed as first generation “”capture agents”” for the AD-specific antibodies in a multiplexed Luminex-like diagnostic assay. If this R21 preliminary investigation is successful, it would set the stage for compound optimization and a much larger validation trial that could lead to an effective blood test for AD.

    Further information available at:

Types: Investments < €500k
Member States: United States of America
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF